Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Sales | 57 | 53 | 140 | 90 | 752 |
| Cost of Goods | 0 | -149 | 4 | 0 | 293 |
| Gross Profit | 57 | 202 | 136 | 90 | 460 |
| Operating Expenses | 501 | 415 | 549 | 313 | 254 |
| Operating Income | -443 | -214 | -413 | -223 | 206 |
| Other Income | -36 | -11 | 0 | 0 | -169 |
| Pre-tax Income | -479 | -224 | -413 | -223 | 36 |
| Net Income Continuous | -479 | -224 | -413 | -223 | 36 |
| Net Income | $-479 | $-224 | $-413 | $-223 | $36 |
| EBITDA(a) | $-414 | $-191 | $-397 | $-207 | $222 |